A Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy



Status:Recruiting
Healthy:No
Age Range:2 - 21
Updated:1/13/2019
Start Date:September 30, 2018
End Date:April 2020
Contact:Tianna Aronson
Email:tianna.d.aronson@medtronic.com
Phone:(508) 261-6049

Use our guide to learn which trials are right for you!

A Prospective, Multi-center, Single Arm Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy

The purpose of this study is to assess safety and performance with the use of the BiZact™
device in tonsillectomy procedures in children and adolescents.

A prospective, multi-center, single arm, study of BiZact™ on children and adolescents
undergoing tonsillectomy.

Study Visits:

- Screening/Baseline

- Surgery, Day 0

- Post-Op Follow-up Day 1 - Day 7, Day 10, & Day 14 (Home assessments)

- Post-Op Follow-up Day 28 (Office Visit)

Inclusion Criteria:

- Children and adolescent subjects 2-21 years of age at the time of the procedure,
inclusive

- Scheduled to undergo tonsillectomy

- The Subject or (if the subject is a minor) Subject's Parent/Legally Authorized
Representative (LAR) is willing to participate and consents to participate, as
documented by signed informed consent form and/ or assent form (as applicable)

Exclusion Criteria:

- Subjects undergoing:

1. Tonsillectomy as a result of cancer

2. Unilateral tonsillectomy

- Subjects with:

1. Known bleeding disorders

2. Current peritonsillar abscess

3. Craniofacial disorders

4. Down's syndrome (Trisomy 21)

5. Cerebral palsy

6. Major heart disease (including but not limited to; right-sided heart failure,
left-sided heart failure, congestive heart failure, coronary artery disease,
arrhythmias, chronic heart failure, acute heart failure, etc.)

7. Current tobacco use

- Subjects unable to comply with the required study follow-up visits

- Female subjects pregnant at time of procedure.

- The subject has comorbidities which, in the opinion of the Investigator, will not be
appropriate for the study or the subject has an estimated life expectancy - The
subject is participating or has participated in any drug or device research study
within 30 days of enrollment.
We found this trial at
3
sites
Charlotte, North Carolina 28210
Principal Investigator: Eric Mair
Phone: 704-295-3393
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
2051 Charlie Hall Boulevard
Charleston, South Carolina 29414
Principal Investigator: William Brand
Phone: 843-518-5642
?
mi
from
Charleston, SC
Click here to add this to my saved trials
North Adelaide,
Principal Investigator: David Wabnitz
?
mi
from
North Adelaide,
Click here to add this to my saved trials